[Pathogenesis of systemic scleroderma: immunological aspects].
Systemic sclerosis (SSc) is a connective tissue disorder that is characterized by excessive collagen synthesis by fibroblasts and by vascular hyperreactivity and obliteration phenomena. Excessive collagen production is the consequence of abnormal interactions between endothelial cells, fibroblasts and mononuclear cells. Immunological abnormalities are present very early in the development of SSc. Mononuclear cells, particularily macrophages and T lymphocytes play a prominent role in fibroblast activation and collagen synthesis through the cytokines they produce. Thus, lymphocytic infiltrates in the skin and in the lung are preferentially composed of CD8+ T lymphocytes, that produce important amounts of interleukin 4 (IL-4). The effects of IL-4 are added to these of transforming growth factor B (TGF-B) and connective tissue growth factor (CTGF) that stimulate collagen synthesis by fibroblasts. T lymphocytes produce important amounts of gamma interferon (INF-gamma) that is the best inhibitor of collagen synthesis by fibroblasts. However, the inhibitory effect of INF-gamma on collagen synthesis is diminished in SSc patients. Numerous autoantibodies can be evidenced in the serum of SSc patients. Three of them are specific for SSc and mutually exclusive: anti-centromere antibodies (Ab) in limited SSc, anti-Scl70 Ab in diffuse SSc and anti-RNA polymerase III Ab in diffuse SSc with renal involvement. These autoantibodies are good prognosis markers but their pathogenic role remains uncertain.
Mouthon
Luc
L
Service de Médecine Interne, Hôpital Avicenne, Assistance Public, Hôpitaux de Paris, et Université Paris Nord, 125, route de Stalingrad, 93009 Bobigny.
García De La Peña-Lefebvre
Paloma
P
Chanseaud
Youri
Y
Tamby
Mathieu C
MC
Boissier
Marie-Christophe
MC
Guillevin
Loïc
L
D001323:Autoantibodies / Q000276:immunology; D003094:Collagen / Q000276:immunology; D016207:Cytokines / Q000276:immunology; D005347:Fibroblasts / Q000276:immunology; D006133:Growth Substances / Q000276:immunology; D006801:Humans; D007111:Immunity, Cellular; D015847:Interleukin-4 / Q000276:immunology; D012595:Scleroderma, Systemic / Q000276:immunology*; D013601:T-Lymphocytes / Q000276:immunology; D016212:Transforming Growth Factor beta / Q000276:immunology
D001323:Autoantibodies; D016207:Cytokines; D006133:Growth Substances; D016212:Transforming Growth Factor beta; D015847:Interleukin-4; D003094:Collagen